4basebio PLC
5.75
EUR
+0.05
(+0.88%)
Important Dates
4basebio PLC's next confirmed earnings release is scheduled for June 2, 2027.
| Earnings Date | 6/2/2027 |
Share Statistics
As of December 31, 2025, 4basebio PLC has 15.48M shares outstanding.
| Shares Outstanding | 15.48M |
Financial Position
As of December 31, 2025, 4basebio PLC maintains a current ratio of 7.31, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.31 |
| Quick Ratio | 6.30 |
| Debt / Equity | 165.38 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 125.00 |
Balance Sheet
EURAs of December 31, 2025, 4basebio PLC holds 20.42M in cash and equivalents against 19.18M in total debt, resulting in a net debt position of -2.18M. Total book value stands at 11.60M, with working capital of 20.45M providing operational flexibility.
| Cash & Cash Equivalents | 20.42M |
| Total Debt | 19.18M |
| Net Debt | -2.18M |
| Equity (Book Value) | 11.60M |
| Book Value Per Share | 0.75 |
| Working Capital | 20.45M |